Search results for "Vaccines"
Q&A with ACP's President on COVID-19 vaccines
George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021
Staying safe on social media
Despite the risks of impersonation or harassment, physicians say participating in social media has considerable professional and personal benefits.
https://immattersacp.org/archives/2023/06/staying-safe-on-social-media.htm
1 Jun 2023
New data on delta variant of COVID-19 and vaccines
Recent research found that the risk of myocarditis and both arterial and venous clots is higher with COVID-19 infection than with vaccine administration. Other studies show that the COVID-19 delta variant has been associated with reduced mRNA vaccine effectiveness (from 91% to 66%) and an overall increased severity of illness.
https://immattersacp.org/weekly/archives/2021/08/31/1.htm
31 Aug 2021
Research, news about COVID-19 vaccines, resources from ACP on flu vaccination
Results of vaccine trials were positive, but concerns arose about safety.
https://immattersacp.org/weekly/archives/2020/09/15/1.htm
15 Sep 2020
Earn trust, counter misinformation
Physicians are on the front lines of addressing medical misinformation, increasingly figuring out what to address and how.
https://immattersacp.org/archives/2023/06/earn-trust-counter-misinformation.htm
1 Jun 2023
New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’
The Johnson & Johnson COVID-19 vaccine got an emergency use authorization, and an Israeli study provided more data on the Pfizer vaccine. The NIH recommended an antibody combo for outpatients and named long-term symptoms as post-acute sequelae of SARS-CoV-2 (PASC).
https://immattersacp.org/weekly/archives/2021/03/02/1.htm
2 Mar 2021
Expensive vaccines may wipe out wrong target—the doctor
New and expensive vaccines added to the schedule for adolescents, adults and children over the last several years have created a crisis in the delivery system that threatens to reduce or eliminate the private provider's role, say experts following the issue.
https://immattersacp.org/archives/2009/04/vaccine.htm
1 Apr 2009
Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging
An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
https://immattersacp.org/weekly/archives/2021/07/20/1.htm
20 Jul 2021
New authorization, guidance on vaccines against SARS-CoV-2
The Moderna COVID-19 vaccine was authorized by the FDA and recommended by the CDC, additional guidance was issued on the use of the Pfizer-BioNTech vaccine, and ACP and Annals of Internal Medicine held a forum on encouraging vaccine uptake.
https://immattersacp.org/weekly/archives/2020/12/22/1.htm
22 Dec 2020
New COVID-19 boosters, DNA test for cancer risk OK’ed
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/11/new-covid-19-boosters-dna-test-for-cancer-risk-oked.htm
1 Nov 2023